Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,408 | -460 | -2,047 | -1,559 | -1,035 |
| Depreciation Amortization | 137 | 64 | 384 | 279 | 172 |
| Accounts receivable | 2 | 1 | -21 | -15 | -15 |
| Accounts payable and accrued liabilities | 36 | -9 | 51 | -30 | -9 |
| Other Working Capital | 292 | 77 | 211 | 23 | -86 |
| Other Operating Activity | 3,362 | -1 | 258 | 359 | 280 |
| Operating Cash Flow | $-579 | $-328 | $-1,164 | $-944 | $-693 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -26 | -26 | -26 |
| Other Investing Activity | 0 | 0 | -25 | -25 | -25 |
| Investing Cash Flow | $N/A | $N/A | $-51 | $-51 | $-51 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 463 | 448 | 1,604 | 1,276 | 810 |
| Debt Repayment | -234 | -110 | -526 | -427 | -313 |
| Other Financing Activity | 337 | 0 | 113 | 113 | 290 |
| Financing Cash Flow | $567 | $338 | $1,191 | $962 | $787 |
| Beginning Cash Position | 12 | 12 | 36 | 36 | 36 |
| End Cash Position | N/A | 22 | 12 | 4 | 79 |
| Net Cash Flow | $-12 | $10 | $-24 | $-33 | $43 |
| Free Cash Flow | |||||
| Operating Cash Flow | -579 | -328 | -1,164 | -944 | -693 |
| Capital Expenditure | N/A | N/A | -26 | -26 | -26 |
| Free Cash Flow | -579 | -328 | -1,190 | -970 | -720 |